These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15777990)

  • 1. Polymorphisms related to estrogen and xenobiotic metabolism in healthy Turkish women.
    Kocabaş NA; Sardaş S; Karakaya AE
    Arch Med Res; 2005; 36(1):19-23. PubMed ID: 15777990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
    McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
    Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Elhan AH; Karakaya AE
    Cell Biochem Funct; 2005; 23(1):73-6. PubMed ID: 15386537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
    Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
    Saintot M; Malaveille C; Hautefeuille A; Gerber M
    Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
    Cerne JZ; Novakovic S; Frkovic-Grazio S; Pohar-Perme M; Stegel V; Gersak K
    Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between genetic polymorphisms and ovarian cancer risk.
    Delort L; Chalabi N; Satih S; Rabiau N; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(5B):3079-81. PubMed ID: 19031960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women.
    Yadav S; Singhal NK; Singh V; Rastogi N; Srivastava PK; Singh MP
    Dis Markers; 2009; 27(5):203-10. PubMed ID: 20037207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in 2-hydroxyestrone and 16alpha-hydroxyestrone metabolism with flaxseed consumption: modification by COMT and CYP1B1 genotype.
    McCann SE; Wactawski-Wende J; Kufel K; Olson J; Ovando B; Kadlubar SN; Davis W; Carter L; Muti P; Shields PG; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):256-62. PubMed ID: 17301257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
    Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
    Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
    Dumas I; Diorio C
    BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
    Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
    Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
    Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
    Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk.
    Ahsan H; Chen Y; Whittemore AS; Kibriya MG; Gurvich I; Senie RT; Santella RM
    Breast Cancer Res Treat; 2004 May; 85(2):121-31. PubMed ID: 15111770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
    Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
    Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
    Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
    Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.
    Rylander-Rudqvist T; Wedren S; Granath F; Humphreys K; Ahlberg S; Weiderpass E; Oscarson M; Ingelman-Sundberg M; Persson I
    Carcinogenesis; 2003 Sep; 24(9):1533-9. PubMed ID: 12844487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk.
    Nock NL; Cicek MS; Li L; Liu X; Rybicki BA; Moreira A; Plummer SJ; Casey G; Witte JS
    Carcinogenesis; 2006 Sep; 27(9):1842-8. PubMed ID: 16569655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.